Cargando…
Abstract 32 Low Incidence of Product Complaints and Adverse Events Support Safety of Cord Blood Units
INTRODUCTION: As an important cellular therapy source for many patients, the safe and timely delivery of cord blood units (CBU) is paramount. The National Marrow Donor Program (NMDP) investigates product complaints received for CBUs distributed under the 10-CBA investigational new drug application t...
Autores principales: | O’Gara, Erin, Regan, Donna, Rice, Lindsay, Bakken, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446952/ http://dx.doi.org/10.1093/stcltm/szac057.032 |
Ejemplares similares
-
Abstract 8 Cord Blood – Defining Urgency & Delivering Speed
por: Regan, Donna, et al.
Publicado: (2023) -
Abstract 28 Comparative Analysis of the Cord Blood Bank in Quebec
por: Lemieux, William, et al.
Publicado: (2022) -
Abstract 31 Testing of Cord Blood Units for Non-Hematopoietic Markers
por: Frenet, Emeline Masson, et al.
Publicado: (2022) -
Abstract 30 Should Cord Blood Unit Distribution Patterns Impact Collection Strategies?
por: Frenet, Emeline Masson, et al.
Publicado: (2022) -
Abstract 26 HLA Analysis of the Australian Cord Blood Banks: How Diverse Are Donors?
por: Klamer, Guy, et al.
Publicado: (2022)